CONFERENCES

      Scientific Meeting of the Cardiac Society of Australia and New Zealand

      Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand (CSANZ) is an conference that explores the latest developments in cardiology research and treatment in Australia and New Zealand, with topics ranging from basic science to clinical trials. The conference is aimed at cardiologists, researchers, and other professionals involved in the study and treatment of cardiovascular disease in Australia and New Zealand, and provides a forum for sharing knowledge and collaborating on new approaches to diagnosis and therapy.

      68th CSANZ Scientific Meeting 2020

      Date

      Dec 11, 2020 - Dec 13, 2020

      Location

      Adelaide, Brisbane, Sydney and Wellington, Australia

      Online

      The 68th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand connects over 1,400 registrants through a virtual platform as well as physical hubs set in Adelaide, Brisbane, Sydney, and Wellington. 

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.